
Tourmaline Bio Inc.
TRML | NASDAQ
$47.98
$0 (0.00%)
At close: Oct 28, 2025, 4:00 PM ET
Market Data
Market Cap $1.23B
Enterprise Value $993.56M
Beta 1.58
Average Volume N/A
Shares Outstanding (Diluted) 25.76M
Shares Change YoY 0.12%
Institutional Ownership 93.44%
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 0.6%
1Y CAGR (ann.) 74.8%
5Y CAGR (ann.) N/A
All-Time CAGR -8.7%
Valuation
PE Ratio -13.99
Forward PE N/A
PEG Ratio 0.78
Forward PEG -1.79
PS Ratio 30,816.28
Forward PS 74.00
PB Ratio 4.76
P/FCF Ratio -14.28
P/Adj. FCF Ratio -13.05
P/OCF Ratio -29.44
EV/Sales 24,839.05
EV/EBIT -10.71
EV/EBITDA -9.70
EV/FCF -11.51
Earnings Yield -7.2%
FCF Yield -7.0%
Adj. FCF Yield -7.7%
Financial Health
Net Cash $239.09M
Total Debt $145K
Cash & Short-Term Investments $239.23M
Total Assets $269.3M
Current Ratio 24.68
Quick Ratio 24.68
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt -595.01
Interest Coverage 0.00
Altman Z-Score 72.19
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin -256122.5%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin -215752.5%
Adj. FCF Margin -236140.0%
SBC / Revenue 0.0%
SBC Impact (per share) -9.4%
Returns
Return on Assets -17.1%
Return on Equity -17.1%
Return on Invested Capital -20.1%
Return on Capital Employed -20.1%
Return on Tangible Assets -17.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 2.6%
Revenue CAGR 5Y 50.9%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -35.3%
EPS CAGR 5Y 61.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y -52.0%
FCF CAGR 5Y -19.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 10
EPS Growth Next 3Y -10.7%
Revenue Growth Next 3Y 1044.3%
Earnings Date Nov 5, 2025
EPS Estimate (next Q) -$0.96
EPS Growth Est (next Q) 23.1%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $48.50
Price Target Upside 1.1%
Cash Flow
Operating Cash Flow $-86.28M
Free Cash Flow $-86.3M
Adj. Free Cash Flow $-94.46M
FCF Per Share -$1.63
OCF Per Share -$1.63
OCF/S Ratio 0.0%
Income Statement
Revenue $40K
Gross Profit $-2K
Operating Income $-102.45M
EBITDA $-102.47M
Net Income $-88.47M
EPS (Diluted) -$3.43
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove TRML